Cabaletta Bio, Inc. Common Stock | CABA

Daily Technical Analysis of Cabaletta Bio, Inc. Common Stock

Geez, brutal day for Cabaletta Bio, investors dumped shares on the market and there weren't too many buyers interested in picking them up which causes price to plunge. Negative outlook for the company may continue to hammer the stock. We'll see if we hit bottom here and get some buyers to come in fishing for value.

Currently CABA isn't at a clear support/resistance line that seems tradable. Cabaletta Bio hasn't been looking too hot recently, some shareholders have been dumping shares over the last few months which has been driving prices down. In the past 3 months, the asset has lost -60.63 of it's value. So it's not looking great, I'd probably wait for a clearer support level before coming in. CABA might find some support at the 13.16 level, buyers might push the price back up from here. But it's not very clear what will happen.

Analyst Ratings for Cabaletta Bio By Price Target And Rating

The analysts feel fairly neutral on the prospects for Cabaletta Bio but a little more positive than negative. The current Analysts Sentiment Score is 17.78. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2024-04-05 and they set their price target at $50.00. On 2024-04-04 Citigroup increased their price target by 15.38% to $30.00. Wells Fargo & Company boosted their price targ by 2.94% to $35.00 on 2024-03-22. HC Wainwright gave a boost to their price target and moved to $30.00 from $25.00 on 2024-03-22. Jefferies Financial Group initiated a rating of Buy on 2024-02-05 and provided a price target of $36.00. William Blair reiterated a rating of Outperform on 2023-11-29 and they set their price target at $38.00. Morgan Stanley announced a lowering of their price target to $25.00 from $28.00 on 2023-11-29. Stifel Nicolaus initiated a rating of Buy on 2023-10-19 and provided a price target of $31.00. Guggenheim reiterated a rating of Buy on 2023-08-14 and they set their price target at $34.00.

Earnings Per Share (EPS) Estimates By Year and Quarter

Short interest for Cabaletta Bio

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Social Sentiment for Cabaletta Bio

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.